Bausch Health Companies (BHC) Change in Cash (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Cash came in at -$13.0 million in Q1 2026, up 70.45% year-on-year from -$7.6 million in Q1 2025, and up 13.33% quarter-over-quarter from -$15.0 million in Q4 2025.
Bausch Health Companies (BHC) Change in Cash (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Cash across 18 years of filings, most recently posting -$13.0 million for Q1 2026.
- Change in Cash for Q1 2026 came in at -$13.0 million, up 70.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $155.0 million (down 61.44% YoY), and the FY2025 annual result was $124.0 million, down 48.12% from the prior year.
- Change in Cash came in at -$13.0 million for Q1 2026 at Bausch Health Companies, up from -$15.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $586.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
- The 5-year median for Change in Cash is -$13.0 million (2026), against an average of -$47.5 million.
- Across the five-year window, Change in Cash tumbled 9771.43% in 2022 and soared 543.94% in 2025, its largest moves.
- Bausch Health Companies' Change in Cash stood at $94.0 million in 2022, then surged by 93.62% to $182.0 million in 2023, then surged by 147.8% to $451.0 million in 2024, then tumbled by 103.33% to -$15.0 million in 2025, then grew by 13.33% to -$13.0 million in 2026.
- The last three Change in Cash figures came in at -$13.0 million (Q1 2026), -$15.0 million (Q4 2025), and -$403.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 185.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -509.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -117.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.23 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -6.35 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.47 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | -13.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.00 Mn |
| Dec 31, 2025 | -15.00 Mn |
| Sep 30, 2025 | -403.00 Mn |
| Jun 30, 2025 | 586.00 Mn |
| Mar 31, 2025 | -44.00 Mn |
| Dec 31, 2024 | 451.00 Mn |
| Sep 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | -132.00 Mn |
| Mar 31, 2024 | -207.00 Mn |
| Dec 31, 2023 | 182.00 Mn |
| Sep 30, 2023 | 192.00 Mn |
| Jun 30, 2023 | 57.00 Mn |
| Mar 31, 2023 | -60.00 Mn |
| Dec 31, 2022 | 94.00 Mn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -581.00 Mn |
| Mar 31, 2022 | 341.00 Mn |
| Dec 31, 2021 | 215.00 Mn |
| Sep 30, 2021 | -14.00 Mn |
| Jun 30, 2021 | -29.00 Mn |